SCOPUS 정보 검색 플랫폼

Clinical and Experimental Allergy Reviews

Volumn 6, Issue 1, 2006, Pages 25-29

Business and science: A partnership for the benefit of allergic patients

(2) De Vos, Ch a Bachert, C b

a UCB PHARMA (Belgium)

b GHENT UNIVERSITY HOSPITAL (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BUCLIZINE; CETIRIZINE; HYDROXYZINE; LEVOCETIRIZINE; MECLOZINE;

ALLERGIC RHINITIS; ALLERGY; ATOPIC DERMATITIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG INDUSTRY; FATIGUE; HUMAN; PATHOGENESIS; PATIENT; PRIORITY JOURNAL; SCIENCE; SEDATION; SIDE EFFECT; SOMNOLENCE; URTICARIA;

EID: 33645021615 PISSN: 14729725 EISSN: None Source Type: Journal
DOI: 10.1111/j.1365-2222.2005.00098.x Document Type: Conference Paper

Times cited : (3)

References (7)

1
- 85004775232
- Clin Allergy
- Fadel R Herpin-Richard N Rihoux JP Henocq E. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo Clin Allergy 1987 17 373 9
- (1987) Inhibitory Effect of Cetirizine 2HCl on Eosinophil Migration in Vivo , vol.17 , pp. 373-9
- Fadel, R.¹ Herpin-Richard, N.² Rihoux, J.P.³ Henocq, E.⁴

2
- 0035217144
- Warner JO for the ETAC™ Study Group. 18 months' treatment and 18 months' posttreatment follow-up J Allergy Clin Immunol
- Warner JO for the ETAC™ Study Group A double blind, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis 18 months' treatment and 18 months' posttreatment follow-up J Allergy Clin Immunol 2001 108 929 37
- (2001) A Double Blind, Randomized, Placebo-controlled Trial of Cetirizine in Preventing the Onset of Asthma in Children with Atopic Dermatitis , vol.108 , pp. 929-37

3
- 4944246449
- J Allergy Clin Immunol
- Bachert C Bousquet J Canonica GW et al Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis J Allergy Clin Immunol 2004 114 838 44
- (2004) Levocetirizine Improves Quality of Life and Reduces Costs in Long-term Management of Persistent Allergic Rhinitis , vol.114 , pp. 838-44
- Bachert, C.¹ Bousquet, J.² Canonica, G.W.³ Al, E.⁴

4
- 0002885825
- J Allergy Clin Immunol
- Bousquet J Van Cauwenberge P Khaltaev N ARIA Workshop Group, World Health Organization Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 2001 108 S147 334
- (2001) Allergic Rhinitis and Its Impact on Asthma , vol.108 , pp. 147-334
- Bousquet, J.¹ Van Cauwenberge, P.² Group Workshop Aria, K.N.³ Health Organization, W.⁴

5
- 20044377632
- Allergy
- Bousquet J Demarteau N for the XPERT study group et al Costs associated with persistent allergic rhinitis are reduced by levocetirizine Allergy 2005 60 788 94
- (2005) Costs Associated with Persistent Allergic Rhinitis Are Reduced by Levocetirizine , vol.60 , pp. 788-94
- Bousquet, J.¹ Group Study Xpert The For, D.N.² Al, E.³

6
- 38349116758
- Europ Respir J
- ™ Study Group. Efficacy and safety of levocetirizine in persistent allergic rhinitis (PER) Europ Respir J 2005 26 suppl. 49 136S
- (2005) Efficacy and Safety of Levocetirizine in Persistent Allergic Rhinitis (PER) , vol.26 , Issue.49 SUPPL.
- Van Cauwenberge, P.¹

7
- 1842567770
- Levocetirizine long-term treatment in patients suffering from persistent allergic rhinitis Allergy
- Bachert C Bousquet J Canonica GW et al XPERT™ Levocetirizine long-term treatment in patients suffering from persistent allergic rhinitis Allergy 2003 58 Suppl. 74 77
- (2003) XPERT™ , vol.58 , Issue.74 SUPPL. , pp. 77
- Bachert, C.¹ Bousquet, J.² Canonica, G.W.³ Al, E.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.